Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO Post author:Sam Post published:November 7, 2017 Post category:BioPharma OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company. Source: BioSpace You Might Also Like Johnson & Johnson Yanks Plans for First R&D Facility in the UK November 27, 2017 Bay Area's DNAnexus Scores $58M to Accelerate Expansion January 1, 2018 Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug July 4, 2017